{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:37:44Z","timestamp":1777426664305,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"10128","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/s0140-6736(18)30291-5","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T18:53:06Z","timestamp":1522349586000},"page":"1378-1390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Pyronaridine\u2013artesunate or dihydroartemisinin\u2013piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial"],"prefix":"10.1016","volume":"391","author":[{"given":"Issaka","family":"Sagara","sequence":"first","affiliation":[]},{"given":"Abdoul Habib","family":"Beavogui","sequence":"additional","affiliation":[]},{"given":"Issaka","family":"Zongo","sequence":"additional","affiliation":[]},{"given":"Issiaka","family":"Soulama","sequence":"additional","affiliation":[]},{"given":"Isabelle","family":"Borghini-Fuhrer","sequence":"additional","affiliation":[]},{"given":"Bakary","family":"Fofana","sequence":"additional","affiliation":[]},{"given":"Aliou","family":"Traore","sequence":"additional","affiliation":[]},{"given":"Nouhoum","family":"Diallo","sequence":"additional","affiliation":[]},{"given":"Hamadoun","family":"Diakite","sequence":"additional","affiliation":[]},{"given":"Amadou H","family":"Togo","sequence":"additional","affiliation":[]},{"given":"Sekou","family":"Koumare","sequence":"additional","affiliation":[]},{"given":"Mohamed","family":"Keita","sequence":"additional","affiliation":[]},{"given":"Daouda","family":"Camara","sequence":"additional","affiliation":[]},{"given":"Anyir\u00e9kun F","family":"Som\u00e9","sequence":"additional","affiliation":[]},{"given":"Aboubacar S","family":"Coulibaly","sequence":"additional","affiliation":[]},{"given":"Oumar B","family":"Traore","sequence":"additional","affiliation":[]},{"given":"Souleymane","family":"Dama","sequence":"additional","affiliation":[]},{"given":"Siaka","family":"Goita","sequence":"additional","affiliation":[]},{"given":"Moussa","family":"Djimde","sequence":"additional","affiliation":[]},{"given":"Amadou","family":"Bamadio","sequence":"additional","affiliation":[]},{"given":"Niawanlou","family":"Dara","sequence":"additional","affiliation":[]},{"given":"Hamma","family":"Maiga","sequence":"additional","affiliation":[]},{"given":"Bouran","family":"Sidibe","sequence":"additional","affiliation":[]},{"given":"Francois","family":"Dao","sequence":"additional","affiliation":[]},{"given":"Moctar","family":"Coulibaly","sequence":"additional","affiliation":[]},{"given":"Mohamed Lamine","family":"Alhousseini","sequence":"additional","affiliation":[]},{"given":"Hamidou","family":"Niangaly","sequence":"additional","affiliation":[]},{"given":"Boubou","family":"Sangare","sequence":"additional","affiliation":[]},{"given":"Modibo","family":"Diarra","sequence":"additional","affiliation":[]},{"given":"Samba","family":"Coumare","sequence":"additional","affiliation":[]},{"given":"Mo\u00efse J T","family":"Kabore","sequence":"additional","affiliation":[]},{"given":"San Maurice","family":"Ouattara","sequence":"additional","affiliation":[]},{"given":"Aissata","family":"Barry","sequence":"additional","affiliation":[]},{"given":"D\u00e9sir\u00e9","family":"Kargougou","sequence":"additional","affiliation":[]},{"given":"Amidou","family":"Diarra","sequence":"additional","affiliation":[]},{"given":"Noelie","family":"Henry","sequence":"additional","affiliation":[]},{"given":"Harouna","family":"Sor\u00e9","sequence":"additional","affiliation":[]},{"given":"Edith C","family":"Bougouma","sequence":"additional","affiliation":[]},{"given":"Ismaila","family":"Thera","sequence":"additional","affiliation":[]},{"given":"Yves D","family":"Compaore","sequence":"additional","affiliation":[]},{"given":"Colin J","family":"Sutherland","sequence":"additional","affiliation":[]},{"given":"Malick Minkael","family":"Sylla","sequence":"additional","affiliation":[]},{"given":"Frederic","family":"Nikiema","sequence":"additional","affiliation":[]},{"given":"Mamadou Saliou","family":"Diallo","sequence":"additional","affiliation":[]},{"given":"Alassane","family":"Dicko","sequence":"additional","affiliation":[]},{"given":"Stephane","family":"Picot","sequence":"additional","affiliation":[]},{"given":"Steffen","family":"Borrmann","sequence":"additional","affiliation":[]},{"given":"Stephan","family":"Duparc","sequence":"additional","affiliation":[]},{"given":"Robert M","family":"Miller","sequence":"additional","affiliation":[]},{"given":"Ogobara K","family":"Doumbo","sequence":"additional","affiliation":[]},{"given":"Jangsik","family":"Shin","sequence":"additional","affiliation":[]},{"given":"Jose Pedro","family":"Gil","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[]},{"given":"Jean-Bosco","family":"Ouedraogo","sequence":"additional","affiliation":[]},{"given":"Sodiomon B","family":"Sirima","sequence":"additional","affiliation":[]},{"given":"Abdoulaye A","family":"Djimde","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(18)30291-5_bib1","series-title":"World Malaria Report, 2016","year":"2016"},{"key":"10.1016\/S0140-6736(18)30291-5_bib2","series-title":"Guidelines for the treatment of malaria","year":"2015"},{"key":"10.1016\/S0140-6736(18)30291-5_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4269\/ajtmh.2012.11-0649","article-title":"Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact","volume":"87","author":"Sagara","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S0140-6736(18)30291-5_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1475-2875-10-237","article-title":"Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial","volume":"10","author":"Ndiaye","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/S0140-6736(18)30291-5_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1475-2875-7-127","article-title":"Amodiaquine-artesunate vs artemether\u2013lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up","volume":"7","author":"Adjei","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/S0140-6736(18)30291-5_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/cid\/cir066","article-title":"Efficacy and effectiveness of artemether\u2013lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial","volume":"52","author":"Ngasala","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0140-6736(18)30291-5_bib7","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/S2214-109X(16)30236-4","volume":"5","author":"Mavoko","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S0140-6736(18)30291-5_bib8","series-title":"WHO policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa","year":"2012"},{"key":"10.1016\/S0140-6736(18)30291-5_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1475-2875-12-70","article-title":"Safety and efficacy of pyronaridine\u2013artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials","volume":"12","author":"Duparc","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/S0140-6736(18)30291-5_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1475-2875-11-364","article-title":"Pyronaridine\u2013artesunate granules versus artemether\u2013lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial","volume":"11","author":"Kayentao","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/S0140-6736(18)30291-5_bib11","doi-asserted-by":"crossref","first-page":"e14501","DOI":"10.1371\/journal.pone.0014501","article-title":"Pyronaridine\u2013artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial","volume":"6","author":"Poravuth","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S0140-6736(18)30291-5_bib12","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1007125","article-title":"Pyronaridine\u2013artesunate versus mefloquine plus artesunate for malaria","volume":"366","author":"Rueangweerayut","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(18)30291-5_bib13","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(10)60322-4","article-title":"Efficacy and safety of a fixed-dose oral combination of pyronaridine\u2013artesunate compared with artemether\u2013lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial","volume":"375","author":"Tshefu","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)30291-5_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1473-3099(15)00318-7","article-title":"Safety and efficacy of re-treatments with pyronaridine\u2013artesunate in African patients with malaria: a substudy of the WANECAM randomised trial","volume":"16","author":"Sagara","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S0140-6736(18)30291-5_bib15","doi-asserted-by":"crossref","first-page":"e7871","DOI":"10.1371\/journal.pone.0007871","article-title":"Dihydroartemisinin\u2013piperaquine and artemether\u2013lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial","volume":"4","author":"Bassat","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/S0140-6736(18)30291-5_bib16","doi-asserted-by":"crossref","first-page":"e1101","DOI":"10.1371\/journal.pone.0001101","article-title":"A randomised controlled trial to assess the efficacy of dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated falciparum malaria in Peru","volume":"2","author":"Grande","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/S0140-6736(18)30291-5_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/trstmh\/trs019","article-title":"Efficacy and safety of dihydroartemisinin\u2013piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies","volume":"107","author":"Naing","year":"2013","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S0140-6736(18)30291-5_bib18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(07)60160-3","article-title":"Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison","volume":"369","author":"Ratcliff","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)30291-5_bib19","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0140-6736(06)68931-9","article-title":"Efficacy and effectiveness of dihydroartemisinin\u2013piperaquine versus artesunate\u2013mefloquine in falciparum malaria: an open-label randomised comparison","volume":"367","author":"Smithuis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)30291-5_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1473-3099(10)70187-0","article-title":"Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial","volume":"10","author":"Smithuis","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S0140-6736(18)30291-5_bib21","doi-asserted-by":"crossref","first-page":"e11880","DOI":"10.1371\/journal.pone.0011880","article-title":"An open-label, randomised study of dihydroartemisinin\u2013piperaquine versus artesunate\u2013mefloquine for falciparum malaria in Asia","volume":"5","author":"Valecha","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/S0140-6736(18)30291-5_bib22","doi-asserted-by":"crossref","first-page":"e1001119","DOI":"10.1371\/journal.pmed.1001119","article-title":"A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial","volume":"8","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/S0140-6736(18)30291-5_bib23","article-title":"Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria","volume":"3","author":"Bukirwa","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0140-6736(18)30291-5_bib24","article-title":"Dihydroartemisinin\u2013piperaquine for treating uncomplicated Plasmodium falciparum malaria","volume":"1","author":"Zani","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0140-6736(18)30291-5_bib25","first-page":"263674","article-title":"Does the use of dihydroartemisinin\u2013piperaquine in treating patients with uncomplicated falciparum malaria reduce the risk for recurrent new falciparum infection more than artemether\u2013lumefantrine?","volume":"2014","author":"Akpaloo","year":"2014","journal-title":"Malar Res Treat"},{"key":"10.1016\/S0140-6736(18)30291-5_bib26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1086\/522985","article-title":"Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether\u2013lumefantrine, and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso","volume":"45","author":"Zongo","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0140-6736(18)30291-5_bib27","series-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria","year":"2003"},{"key":"10.1016\/S0140-6736(18)30291-5_bib28","series-title":"Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations","year":"2008"},{"key":"10.1016\/S0140-6736(18)30291-5_bib29","series-title":"Fundamentals of clinical trials","author":"Friedman","year":"2010"},{"key":"10.1016\/S0140-6736(18)30291-5_bib30","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.respe.2010.06.124","article-title":"\u00c9valuation de l'effet de diff\u00e9rentes combinaisons th\u00e9rapeutiques \u00e0 base d'art\u00e9misinine, sur l'incidence du paludisme dans une zone hyperend\u00e9mique de paludisme au Mali","volume":"58","author":"Sagara","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/S0140-6736(18)30291-5_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12936-017-1700-8","article-title":"Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether\u2013lumefantrine treatment in Mali","volume":"16","author":"Dama","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/S0140-6736(18)30291-5_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S0140-6736(18)30291-5_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0091270007310384","article-title":"Safety, tolerability, and single- and multiple-dose pharmacokinetics of piperaquine phosphate in healthy subjects","volume":"48","author":"Ahmed","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/S0140-6736(18)30291-5_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12936-015-0810-4","article-title":"Measuring windows of selection for anti-malarial drug treatments","volume":"14","author":"Kay","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/S0140-6736(18)30291-5_bib35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4269\/ajtmh.16-0234","article-title":"Plasmodium falciparum resistance to artemisinin derivatives and piperaquine: a major challenge for malaria elimination in Cambodia","volume":"95","author":"Duru","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S0140-6736(18)30291-5_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12936-017-1680-8","article-title":"Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin\u2013piperaquine in the south of Vietnam","volume":"16","author":"Thanh","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/S0140-6736(18)30291-5_bib37","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/AAC.00039-16","article-title":"Efficacy and safety of pyronaridine\u2013artesunate for treatment of uncomplicated Plasmodium falciparum malaria in western Cambodia","volume":"60","author":"Leang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0140-6736(18)30291-5_bib38","doi-asserted-by":"crossref","first-page":"e0164851","DOI":"10.1371\/journal.pone.0164851","article-title":"Multi-country evaluation of safety of dihydroartemisinin\/piperaquine post-licensure in african public hospitals with electrocardiograms","volume":"11","author":"Kabanywanyi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S0140-6736(18)30291-5_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12936-017-1712-4","article-title":"Efficacy of artemether\u2013lumefantrine, artesunate\u2013amodiaquine, and dihydroartemisinin\u2013piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015","volume":"16","author":"Plucinski","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/S0140-6736(18)30291-5_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/AAC.04181-14","article-title":"Efficacy of artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine for treatment of uncomplicated malaria in children in Zaire and Uige Provinces, Angola","volume":"59","author":"Plucinski","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673618302915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673618302915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T06:41:57Z","timestamp":1530168117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673618302915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":40,"journal-issue":{"issue":"10128","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0140673618302915"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(18)30291-5","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyronaridine\u2013artesunate or dihydroartemisinin\u2013piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(18)30291-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(18)30630-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}